Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Neopharm

- PMLiVE

Political tensions halt Fresenius’ Russian joint venture

Planned to combine subsidiary with Sistema and Zenitco’s CJSC Binnopharm

Bristol-Myers Squibb (BMS) building

BMS buys immunotherapy specialist Flexus in $1.2bn deal

And signs new cancer research partnership with Rigel

- PMLiVE

Online life sciences mapping tool launched

UK opens up database of 5,000 life science companies and sites

- PMLiVE

Political tensions halt Fresenius’ Russian joint venture

Venture was due to complete by the end of the year

- PMLiVE

UK biotech Retrogenix appoints Matthew Britiz

He takes up role as North American business development director

Novartis day

Novartis licenses Ophthotech eye drug in $1bn deal

Fovista is a potential first-in-class treatment for wet AMD

TxCell plans listing as EU biotech wakes up to IPOs

Move follows UK allergy therapy developer Circassia's listing

- PMLiVE

Galapagos divests CRO operations to pursue biotech path

Sells Argenta and BioFocus to Charles River Laboratories for up to €134m

- PMLiVE

2013 – biotech boomed

The $10bn-plus strategic acquisition returned and pharma companies sought to replenish their pipelines

- PMLiVE

Incubating biotech’s future

The trials of nurturing the next generation of small to medium-sized biotechnology firms

- PMLiVE

BIA elects six new board members

Biotech trade body adds representatives from MedImmune, J&J and more

- PMLiVE

New arrivals join BioHub at AZ’s Alderley Park

Six new biopharma start-ups set up at the UK biocluster

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links